Comparator-Controlled Study for EGFR(+) Patients With Multiple BMs From NSCLC (BROKE) (EGFR-epidermal Growth Factor Receptor;BM-brain Metastases)

NCT02338011 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

210

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer
Brain Metastases
EGFR Gene Mutation

Interventions

DRUG: Gefitinib
RADIATION: WBRT

Sponsor

Shanghai Chest Hospital